IMG_2022-1-11-125620.jpg
Regulatory & Quality23andMe Keeps Snagging FDA Nods for Cancer Marker Tests23andMe Keeps Snagging FDA Nods for Cancer Marker Tests
The Sunnyvale, CA-based company said it has won FDA clearance for a genetic health risk report on a hereditary prostate cancer marker.
Sign up for the QMED & MD+DI Daily newsletter.